Colorectal Cancer Association of Canada - CCAC
Home

News and Resources > News  

03/09/17

OncoBreak: Cancer Center Shakeup; Colon Cancer Risk; Post-Melanoma Suntanning

by Charles Bankhead Senior Associate Editor, MedPage Today March 09, 2017

Citing a need for "a new president who will inspire greater unity and a sharp operational focus," Ronald A. DePinho, M.D, announced his resignation as president of the University of Texas MD Anderson Cancer Center.

Six ways to reduce the risk of colon cancer, during National Colorectal Cancer Awareness month, and beyond. (American Cancer Society)

The American Society of Clinical Oncology removed all restrictions on author relationships with industry, a change that applies to the organization’s journals and presentations at conferences. (Policy and Medicine)

Michigan Medicine launched the nation’s first prostate cancer risk-assessment clinic for men who are carriers of BRCA mutations. (University of Michigan) Studies in mice identified a metabolic weakness that might be exploited to overcome treatment resistance mechanisms in triple-negative breast cancer. (Ludwig Cancer Research)

Patients with relapsed or refractory multiple myeloma lived 7.6 months longer when they were treated with carfilzomib (Kyprolis) instead of bortezomib (Velcade), confirming a previous report of improved progression-free survival with carfilzomib. (Amgen)

A form of functional brain training led to significant improvement in chronic chemotherapy-induced peripheral neuropathy. (MD Anderson Cancer Center) A phase III trial of the VEGF receptor inhibitor fruquintinib met the primary endpoint of improved overall survival in advanced colorectal cancer. (Chi-Med) Increased consumption of soy-based foods was associated with improved survival in breast cancer. (Cancer)

Adjuvant treatment with two HER2-targeted agents plus chemotherapy led to significant improvement in progression-free survival in HER2-positive breast cancer compared with a single anti-HER2 agent and chemotherapy. (Genentech)

Even a melanoma diagnosis did not dissuade some people from suntanning, even to the point of sunburn. (American Association for Cancer Research)


Bookmark and Share

Source: https://www.medpagetoday.com/publichealthpolicy/generalprofessionalissues/63722